Draganfly Inc. (NASDAQ: DPRO) (CSE: DPRO) (FSE: 3U8) (“Draganfly”
or the “Company”), an award-winning, industry-leading drone
solutions and systems developer, is pleased to announce that the
Company has been selected by NuGen Medical Devices Inc. (TSXV:
NGMD) (“NuGen M.D.”), a leader in needle-free drug delivery, and
Coldchain Delivery Systems, Inc. (“Coldchain Delivery Systems”), to
help provide drones and services for the delivery of NuGen M.D.'s
InsuJet™ needle-free injection devices, insulin, and other crucial
medical supplies to affected areas in Ukraine.
Founded in 2017, NuGen M.D. is an emerging
specialty medical device company focused on developing and
commercializing novel drug delivery technologies. The company
commercializes FDA-cleared and CE-approved needle-free injection
systems catering to a wide range of applications.
Working with Revived Soldiers Ukraine (“RSU”), a
non-profit organization dedicated to providing aid to the people of
Ukraine, Draganfly's North American-made Medical Response Drones
will be used to deliver NuGen M.D.’s InsuJet™ needle-free injection
devices, pre-loaded with insulin, to dangerous and hard-to-reach
areas across Ukraine.
NuGen M.D.’s initial donation will be 50
InsuJet™ needle-free injection devices and 5,000 needle-free
disposable syringes filled with insulin. Each device can be safely
used 5,000 times without the risk of needle-stick injury or
cross-contamination. NuGen M.D's InsuJet™ needle-free injection
device has been approved by Health Canada and holds a CE Mark.
Draganfly recently announced that its first
Medical Response Drone was received by Iryna Vashchuk Discipio,
President of RSU, and members of her staff, including pilots, at a
facility in Poland on May 1, 2022. The drone was then transported
to Ukraine, where the Company’s experienced pilots conducted
virtual training with RSU’s drone operators.
Draganfly’s Medical Response Drone is able to
carry up to 35 pounds. When equipped with the Company’s
temperature-managed Medical Response Payload Box, the drone can
transport temperature-sensitive medical supplies, including
insulin/medicines, blood, pharmaceuticals, vaccines, water, and
wound care kits. The innovative payload system on this type of
drone ensures ease of access when top mounted and effective
quick-release operations when bottom mounted.
In addition to donating three drone systems,
Draganfly received an order for its Medical Response and Search and
Rescue Drones from Coldchain Delivery Systems for immediate
deployment with RSU. The Company will provide an initial combined
total of 10 North American-made Medical Response and Search and
Rescue Drones. The total initial order size (subject to conditions)
is up to 200 units.
CNN recently reported that insulin in Ukraine is
in high demand particularly in conflict zones. According to the
International Diabetes Foundation, there are over 2.3 million
people living with diabetes in Ukraine. Many are Type 1 diabetics
that need daily doses of insulin to survive.
“There is an urgent need for insulin and other
life-saving medical supplies across Ukraine. The combination of our
Medical Response Drones and NuGen’s easy-to-use, needle-free
injectors, pre-loaded with insulin, will ensure that RSU can
provide diabetic Ukrainians with the aid they require,” said
Cameron Chell, President and CEO of Draganfly.
“At NuGen M.D., we believe every individual
should have the opportunity to receive healthcare that is
respectful, safe, and empowering. Since tragedy struck Ukraine, we
have been looking for ways to help,” said Michael Wright, President
and CEO of NuGen Medical Devices Inc. “We are grateful to be
working with Draganfly, Coldchain Delivery Systems, and RSU to
ensure Ukrainians in need have access to crucial medical supplies
and equipment.”
About Draganfly
Draganfly Inc. (NASDAQ: DPRO; CSE: DPRO; FSE:
3U8) is the creator of quality, cutting-edge drone solutions,
software, and AI systems that revolutionize the way organizations
can do business and service their stakeholders. Recognized as being
at the forefront of technology for over 20 years, Draganfly is an
award-winning industry leader serving public safety, public health,
mining, agriculture, industrial inspections, security, mapping, and
surveying markets. Draganfly is a company driven by passion,
ingenuity, and the need to provide efficient solutions and
first-class services to its customers around the world with the
goal of saving time, money, and lives.
For more information on Draganfly, please visit us at
www.draganfly.com.For additional investor information, visit
https://www.thecse.com/en/listings/technology/draganfly-inc,
https://www.nasdaq.com/market-activity/stocks/dpro or
https://www.boerse-frankfurt.de/equity/draganfly-inc-1.
Media ContactArian HopkinsEmail:
media@draganfly.com
Company ContactEmail: info@draganfly.com
About NuGen Medical
Devices
NuGen Medical Devices' principal business is the
development and commercialization of innovative needle-free
injection devices and systems for the administration of
subcutaneous medication.
It is developing products using needle-free drug
delivery technology in several important fields including, but not
limited to, anaphylaxis, diabetes, severe migraine, erectile
dysfunction, chronic anemia, neutropenia, autoimmune rheumatoid
arthritis, growth and fertility hormone, psoriasis as well as DNA
and conventional/pediatric vaccines.
For More Information visit: www.nugenmd.com.Twitter: @NuGenMD
LinkedIn: https://www.linkedin.com/company/nugenmd/ For further
information, please contact:Michael WrightPresident and CEONuGen
Medical Devices Inc.Email: mw@nugenmd.comPhone: (514) 992-9484
Investor Relations Contact:Kin Communications
Inc.Email: NGMD@kincommunications.comPhone: (604) 684-6730
About Coldchain
Delivery Systems
Coldchain Delivery Systems is the leader in time
and temperature-sensitive medical material management integrating
proven systems with the documentation fundamental to accreditation
and effective Quality Control Systems. Coldchain Delivery Systems’
remote monitoring system, pre-qualified thermal shippers, inventory
control, fulfillment, and QAQC solutions ensure the Integrity and
Security of its client’s product.
For more information, visit https://coldchain-tech.com.
Forward-Looking Statements
This release contains certain “forward looking
statements” and certain “forward-looking information” as
defined under applicable Canadian securities laws.
Forward-looking statements and information can generally be
identified by the use of forward-looking terminology such as
“may”, “will”, “expect”, “intend”, “estimate”,
“anticipate”, “believe”, “continue”, “plans” or similar
terminology. Forward-looking statements and information are
based on forecasts of future results, estimates of amounts not
yet determinable and assumptions that, while believed by
management to be reasonable, are inherently subject to
significant business, economic and competitive uncertainties
and contingencies. Forward-looking statements include, but are
not limited to, statements with respect to the supply and
effectiveness of the Company’s drones and services for the delivery
of NuGen M.D.'s InsuJet™ needle-free injection devices, insulin,
and other crucial medical supplies to affected areas in Ukraine.
Forward-looking statements and information are subject to
various known and unknown risks and uncertainties, many of
which are beyond the ability of the Company to control or
predict, that may cause the Company’s actual results,
performance or achievements to be materially different from
those expressed or implied thereby, and are developed based on
assumptions about such risks, uncertainties and other
factors set out here in, including but not limited to: the
potential impact of epidemics, pandemics or other public
health crises, including the current outbreak of the novel
coronavirus known as COVID-19 on the Company’s business,
operations and financial condition, the successful
integration of technology, the inherent risks involved in the
general securities markets; uncertainties relating to the
availability and costs of financing needed in the future; the
inherent uncertainty of cost estimates and the potential for
unexpected costs and expenses, currency fluctuations;
regulatory restrictions, liability, competition, loss of key
employees and other related risks and uncertainties disclosed
under the heading “Risk Factors“ in the Company’s most recent
filings filed with securities regulators in Canada on the SEDAR
website at www.sedar.com. The Company undertakes no
obligation to update forward-looking information except as
required by applicable law. Such forward-looking information
represents managements’ best judgment based on information
currently available. No forward-looking statement can be
guaranteed and actual future results may vary materially.
Accordingly, readers are advised not to place undue reliance
on forward-looking statements or information.
Nugen Medical Devices (TSXV:NGMD)
過去 株価チャート
から 11 2024 まで 12 2024
Nugen Medical Devices (TSXV:NGMD)
過去 株価チャート
から 12 2023 まで 12 2024
